Checkpoint Therapeutics Inc (CKPT)
3.43
-0.35
(-9.26%)
USD |
NASDAQ |
Nov 15, 16:00
3.40
-0.03
(-0.87%)
After-Hours: 20:00
Checkpoint Therapeutics Net Income (TTM): -42.47M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -42.47M |
March 31, 2024 | -52.32M |
December 31, 2023 | -51.85M |
September 30, 2023 | -53.74M |
June 30, 2023 | -58.63M |
March 31, 2023 | -56.25M |
December 31, 2022 | -62.62M |
September 30, 2022 | -71.36M |
June 30, 2022 | -72.01M |
March 31, 2022 | -67.01M |
December 31, 2021 | -56.67M |
September 30, 2021 | -37.14M |
June 30, 2021 | -30.80M |
March 31, 2021 | -26.30M |
December 31, 2020 | -23.08M |
September 30, 2020 | -21.68M |
June 30, 2020 | -21.96M |
Date | Value |
---|---|
March 31, 2020 | -22.10M |
December 31, 2019 | -24.71M |
September 30, 2019 | -27.51M |
June 30, 2019 | -31.64M |
March 31, 2019 | -33.49M |
December 31, 2018 | -36.37M |
September 30, 2018 | -30.67M |
June 30, 2018 | -27.25M |
March 31, 2018 | -27.06M |
December 31, 2017 | -22.68M |
September 30, 2017 | -25.08M |
June 30, 2017 | -24.28M |
March 31, 2017 | -23.24M |
December 31, 2016 | -22.46M |
September 30, 2016 | -22.19M |
June 30, 2016 | -20.81M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-72.01M
Minimum
Jun 2022
-21.68M
Maximum
Sep 2020
-44.88M
Average
-51.85M
Median
Dec 2023
Net Income (TTM) Benchmarks
Fortress Biotech Inc | -40.69M |
NovaBay Pharmaceuticals Inc | -10.12M |
Palatin Technologies Inc | -30.42M |
iBio Inc | -24.91M |
Theriva Biologics Inc | -22.27M |